Director at Roivant Sciences Ltd., filing insider transactions between 2026-02-11 and 2026-06-30.
Total Purchases
—
0 transactions
Total Sales
$82.0M
10 transactions
Companies Traded
1
10 total filings
Active Since
2026-02-11
Last: 2026-06-30
Other Reporting Insiders at Roivant Sciences Ltd.
Transaction History
| Date | Ticker | Type | Shares | Price | Value | Owned After | |
|---|
| 2026-06-30 | ROIV | Sale | 12.4K | $35.28 | $437K | 13.69M | SEC ↗ |
| 2026-06-29 | ROIV | Sale | 200.0K | $34.44 | $6.9M | 14.30M | SEC ↗ |
| 2026-06-29 | ROIV | Sale | 600.0K | $34.59 | $20.8M | 13.70M |
President & Immunovant CEO
| 2026-06-26 | ROIV | Sale | 300.8K | $33.92 | $10.2M | 14.83M | SEC ↗ |
| 2026-06-26 | ROIV | Sale | 325.0K | $34.07 | $11.1M | 14.50M | SEC ↗ |
| 2026-02-13 | ROIV | Sale | 150.8K | $26.49 | $4.0M | 15.35M | SEC ↗ |
| 2026-02-13 | ROIV | Sale | 225.0K | $26.50 | $6.0M | 15.13M | SEC ↗ |
| 2026-02-12 | ROIV | Sale | 150.0K | $26.72 | $4.0M | 15.78M | SEC ↗ |
| 2026-02-12 | ROIV | Sale | 275.0K | $26.76 | $7.4M | 15.50M | SEC ↗ |
| 2026-02-11 | ROIV | Sale | 425.0K | $26.67 | $11.3M | 15.93M | SEC ↗ |
Daniel Allen Gold (Roivant Sciences Ltd.) Insider Trades | Tormere